Skip to content

Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Procedure

Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Thymectomy: Short- Term and Long- Term Results

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04223466
Enrollment
100
Registered
2020-01-10
Start date
2020-01-07
Completion date
2027-12-31
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymectomy

Keywords

Video-assisted thoracoscopic surgery, Subxiphoid approach

Brief summary

Surgerys used in thymectomy for myasthenia gravis and anterior mediastinal tumours have become much less invasive in recent years. In our study, the surgical technique which resected the thymus below the xiphoid process and the technique which was regarded as conventional video- assisted thoracoscopic surgery (VATS) thymectomy was compared.

Interventions

PROCEDURESubxiphoid surgery procedure

Subxiphoid procedure for thymectomy

PROCEDUREVATS surgery procedure

VATS procedure for thymectomy

Sponsors

The Second Hospital of Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Thymoma with or without myasthenia gravis; 2. Generalized myasthenia gravis not sensitive to conservative medicine treatment; 3. Good cardiopulmonary function.

Exclusion criteria

1. Cardiopulmonary function can't bear surgery; 2. Generalized myasthenia gravis with MuSK(+).

Design outcomes

Primary

MeasureTime frameDescription
Duration of hospital staywith 7 daysin days
Operation timeone dayin minutes
The amount of blood lossone dayin milliliter
Duration of drainagewith 7 daysin days
Visual Analogue Scale of postoperative painwithin 3 daysin score

Secondary

MeasureTime frameDescription
Recurrence rate5 yearsRecurrence rate after 5 year follow-up of thymectomy for thymoma
Overall survivalwithin 10 yearsOverall survival in rate
Complete remission rates5 yearsComplete remission rates after 5 year follow-up of thymectomy for myasthenia gravis

Countries

China

Contacts

Primary ContactYunpeng Zhao
zyp_baggio@163.com+8618766188692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026